WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-May-2017 (data as of 23-May-2017)
Next overall update Jul-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'3401 Infant (under 12 months) mortality rate: 2
GDP / capita (US$): 10'8911 Child (under 5 years) mortality rate: 2

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 93'384  91'508  89'580  87'614  85'661  69'600  56'397  43'370 
Births 2'472  2'488  2'485  2'458  2'408  1'741  1'871  1'707 
Surviving infants 2'432  2'445  2'441  2'413  2'361  1'688  1'747  1'502 
Pop. less than 5 years 12'608  12'116  11'727  11'129  10'458  8'111  8'863  6'759 
Pop. less than 15 years 31'283  30'344  29'545  28'605  27'626  24'819  23'114  17'348 
Female 15-49 years 23'376  23'090  22'736  22'418  22'114  17'283  12'754  9'799 

Number of reported cases

(Click for retrospective incidence data for Egypt)
Diphtheria
ChartChart
  59  333 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  222  5'432  1'314  405  245  2'633  887  839 
Mumps
ChartChart
  803  5'143  7'626  20'390  1'390 
Pertussis
ChartChart
  49 
Polio*
ChartChart
  565  2'006 
Rubella
ChartChart
  28  53  21  34  35  24 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  321  3'275  2'965 
Tetanus (total)**
ChartChart
  597  4'952  6'644 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Egypt)
Vaccine year result method % card seen                                                
BCG 2013  99  DHS   59  96  96  96  98  95  98  89  72 
DTP1 2013  99  DHS   59  96  95  96  97  94  98 
DTP3 2013  97  DHS   59  95  93  94  97  93  98  87  84 
DTP4          96  92  93 
IPV1         
HepB_BD         
HepB3 2013  97  DHS   59  95  93  94  97  93  98 
Hib3          95  93  94 
JapEnc         
MCV1          95  92  93  96  93  98  87  78 
MCV2          96  92  93  96  92  97 
PCV1         
PCV3         
Pol3 2013  97  DHS   59  95  93  94  97  93  98  87  84 
Rota1         
RotaC         
RCV1          95  92  93  96 
TT2plus 2013  29  DHS   59  77  71  61 
PAB         
VAD1          58  98 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Egypt)
BCG
ChartChart
  96  96  98  95  98  89  50 
DTP1
ChartChart
  94  96  97  94  98  95  80 
DTP3
ChartChart
  93  94  97  93  98  87  57 
HepB3
ChartChart
  93  94  97  93  98 
HepB_BD
ChartChart
 
Hib3
ChartChart
  93  94 
IPV1
 
MCV1
ChartChart
  92  93  96  93  98  86  41 
MCV2
ChartChart
  92  93  96  92  97 
PAB
ChartChart
  86  86  86  86  80  74 
PCV3
ChartChart
 
Pol3
ChartChart
  93  94  97  93  98  87  67 
RCV1
ChartChart
  92  93  96  93  97 
RotaC
ChartChart
 

Number of districts in the country 283  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 88
From 80 to 89% 2
From 50 to 79% 6
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 week; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult 1st contact; +1, +6 months;
HepB_Pediatric birth; Yes
Influenza risk groups; Yes health care workers, Haj and other travellers
MenAC 4, 6, 12, 15 years; Yes
MMR 12, 18 months; Yes
OPV birth; 2, 4, 6, 9, 12, 18 months; Yes
Td 7, 9 years; Yes
TT after 1st trimester; +1, +6 months; +1, +1 years; Yes pregnant women
VitaminA 9, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2018  2013-2018  2015-2016  2010-2014    2010-2014  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 283  27  279  279  27  273  273 

System performance

Total Nº districts in country number 283  279  279  279  275  273  273 
Nº districts with DTP3 coverage >=80% number 256  254  262  262  259  264  267 
% of districts with DTP3 coverage >=80% From 0 to 100% 90  91  94  94  94  97  98 
Nº districts with measles (MCV1) coverage >=95% number 218  196  222  218  242  241  244 
% of districts with MCV1 coverage >=95% From 0 to 100% 77  70  80  78  88  88  89 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100        100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.